https://www.biotechreality.com/2026/10/libtayo-dosing-chmp-positive-opinion-every-six-weeks.html 2026-10-16T18:39:19Z BiotechReality - Information Intelligence System for Biopharma en Regeneron Libtayo Dosing Update: CHMP Recommends EU Approval of Every-Six-Week Cemiplimab Regimen Across All Cancer Types 2026-10-16T18:27:00Z Blog https://www.biotechreality.com/2026/10/lilly-omvoh-comprehensive-disease-control.html 2026-10-15T15:31:12Z BiotechReality - Information Intelligence System for Biopharma en Lilly Omvoh (mirikizumab-mrkz) Delivers Comprehensive Disease Control in Ulcerative Colitis and Deep Remission in Crohn’s Disease at One Year 2026-10-15T15:31:07Z Blog https://www.biotechreality.com/2026/10/charles-river-magellan-zelestrocel.html 2026-10-14T16:16:41Z BiotechReality - Information Intelligence System for Biopharma en Charles River Magellan Collaboration Backs Zelestrocel Osteoarthritis Therapy With cGMP NGS Viral Safety Testing 2026-10-14T16:16:37Z Blog